Doctor Innovates Cell Therapy in India; Seeks to Make Vision Restoration 80% CheaperInnovationBy Rinchen Norbu Wangchuk25 Jan 2022 13:18 ISTThrough its flagship cell therapy product Eyecyte-RPE, Bengaluru-based venture Eyestem seeks to restore sight for patients in the early stages of Age-Related Macular Degeneration (AMD) and arrest losses for those in the later stages.Read More
Bharat Biotech’s Covaxin Gets Emergency Use Nod for Kids; 10 Things to KnowInformationBy Vidya Raja12 Oct 2021 16:47 ISTThe Subject Expert Committee (SEC) has given a nod for emergency use of Bharat Biotech's Covaxin for children between 2 to 18 years of age.Read More
/english-betterindia/media/post_attachments/uploads/2022/01/Eyestem-Dr-Desai-Feature-1643033152.jpg)
/english-betterindia/media/post_attachments/uploads/2020/08/Vaccine_featured.jpg)